Home  >  Products  >  Med21 (mediator complex subunit 21 ) Blocking Peptide (the N terminal of Med21)(100ug)
Med21 (mediator complex subunit 21 ) Blocking Peptide (the N terminal of Med21)(100ug)

Med21 (mediator complex subunit 21 ) Blocking Peptide (the N terminal of Med21)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-Med21 Antibody (ARP35728_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human, Mouse
Presku: AAP35728
Size: 100ug
Weight: 15kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: Med21 is a component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors.
Alternative names: 0610007L03Rik; AI449604; D19234; D6Ertd782e; Srb7; Surb7
See Full Product Listings >